ClinConnect ClinConnect Logo
Search / Trial NCT04607616

Interactive Guidance Therapy With Video Feed-back of Parent and Child With Autism Spectrum Disorder

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Oct 23, 2020

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Autism Spectrum Disorders Interactive Guidance Therapy Video Feed Back

ClinConnect Summary

This clinical trial is studying a new way to help young children with Autism Spectrum Disorder (ASD) and their parents through a method called Interactive Guidance Therapy with video feedback. The aim is to see how this approach can improve the interactions between parents and their children, who are between 18 months and 3 years old. To be eligible, children must have a diagnosed condition of ASD and be able to interact at a developmental level of over 12 months. It's important that one parent, who is involved in daily life with the child, participates directly in the therapy sessions.

Participants in this study can expect to take part in play sessions where they will receive guidance and feedback through video recordings. This can help them learn new ways to communicate and engage with their child. Both parents will need to provide their consent for the child to participate, and the trial is currently looking for families to join. If you think you might be eligible and are interested, it could be a great opportunity to support your child’s development in a meaningful way.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 months to 3 years child at screening
  • Child with a diagnosis of Autism Spectrum Disorder (DSM 5) or pervasive Developmental Disorder (ICD 10)
  • Child with ADI R and ADOS-2 fulfilling the criteria for TSA / PDD at diagnosis
  • Developmental age \> 12 months in motility with the Brunet-Lézine test
  • Child with availability of parent most present in daily life, only this parent participating directly in play sessions
  • Signed Informed consent form by both parents
  • Patient affiliated to the health insurance system
  • Exclusion Criteria:
  • Level of language in French of parents insufficient to benefit from the care and fill in the questionnaires
  • Psychiatric parental pathology interfering with interactions with the child, qualitatively assessed by the referring psychiatrist
  • Severe sensory illness of the child (blindness, deafness, degenerative disease)

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Montpellier, , France

Paris, , France

Montreuil, , France

Paris, , France

Patients applied

0 patients applied

Trial Officials

Benoit QUIROT, MD

Study Director

EPS Ville Evrard

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials